{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:49:05Z","timestamp":1791535745074,"version":"4.3.4"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1093\/jnci\/djag253","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:39:54Z","timestamp":1784893194000},"page":"1796-1798","source":"Crossref","is-referenced-by-count":0,"title":["Racial disparities in breast cancer: looking beyond the recurrence score"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-3085","authenticated-orcid":false,"given":"Rima","family":"Patel","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-2010","authenticated-orcid":false,"given":"Joseph A","family":"Sparano","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"2026100903513074500_djag253-B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3322\/caac.21874","article-title":"Cancer statistics for African American and Black people, 2025","volume":"75","author":"Saka","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026100903513074500_djag253-B2","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Jemal","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"2026100903513074500_djag253-B3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fonc.2020.01022","article-title":"The contribution of race to breast tumor microenvironment composition and disease progression","volume":"10","author":"Kim","year":"2020","journal-title":"Front Oncol"},{"key":"2026100903513074500_djag253-B4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaoncol.2020.7113","article-title":"Deconstructing racial and ethnic disparities in breast cancer","volume":"7","author":"Sparano","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026100903513074500_djag253-B5","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jnci\/djp175","article-title":"Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group","volume":"101","author":"Albain","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026100903513074500_djag253-B6","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/cncr.34241","article-title":"Racial disparity in distant recurrence-free survival in patients with localized breast cancer: a pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials","volume":"128","author":"Kim","year":"2022","journal-title":"Cancer"},{"key":"2026100903513074500_djag253-B7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/jnci\/djr543","article-title":"Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial","volume":"104","author":"Sparano","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"2026100903513074500_djag253-B8","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/PO.17.00059","article-title":"Impact of genetic ancestry on outcomes in ECOG-ACRIN-E5103","volume":"2017","author":"Schneider","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2026100903513074500_djag253-B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"2026100903513074500_djag253-B10","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"2026100903513074500_djag253-B11","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1200\/jco.19.00945","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update-integration of results from TAILORx","volume":"37","author":"Andre","year":"2019","journal-title":"J Clin Oncol"},{"key":"2026100903513074500_djag253-B12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"2026100903513074500_djag253-B13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.6004\/jnccn.2025.0053","article-title":"NCCN Guidelines\u00ae insights: breast cancer, version 5.2025","volume":"23","author":"Gradishar","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"2026100903513074500_djag253-B14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1200\/JCO.20.00853","article-title":"Molecular drivers of oncotype DX, Prosigna, EndoPredict, and the breast cancer index: a TransATAC Study","volume":"39","author":"Buus","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026100903513074500_djag253-B15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jamaoncol.2020.7320","article-title":"Association of race\/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women","volume":"7","author":"Hoskins","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026100903513074500_djag253-B16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnci\/djae314","article-title":"Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial","volume":"117","author":"Abdou","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"2026100903513074500_djag253-B17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djag221","article-title":"Recurrence Score\u00ae gene group components and outcomes in the RxPONDER trial (SWOG S1007)","author":"Abdou","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"2026100903513074500_djag253-B18","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1158\/1078-0432.CCR-09-1450","article-title":"Relationship between topoisomerase 2A RNA expression and recurrence after adjuvant chemotherapy for breast cancer","volume":"15","author":"Sparano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2026100903513074500_djag253-B19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jnci\/djaa148","article-title":"Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial","volume":"113","author":"Albain","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026100903513074500_djag253-B20","doi-asserted-by":"publisher","first-page":"e35771","DOI":"10.1002\/cncr.35771","article-title":"Impact of race\/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: a National Cancer Data Base analysis","volume":"131","author":"Patel","year":"2025","journal-title":"Cancer"},{"key":"2026100903513074500_djag253-B21","doi-asserted-by":"publisher","first-page":"P2-10-08","DOI":"10.1158\/1538-7445.Sabcs19-p2-10-08","article-title":"Abstract P2-10-08: racial disparities in breast cancer: identifying predisposing clinical and molecular features associated with African American patients","volume":"80","author":"Nunes","year":"2020","journal-title":"Cancer Res"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag253\/70833708\/djag253.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/10\/1796\/70833708\/djag253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/10\/1796\/70833708\/djag253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:51:39Z","timestamp":1791532299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/10\/1796\/8772929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,29]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag253","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,29]]}}}